NZ221647A - Di- and triblock copolymers comprising polyalkylene oxide block and a block comprising glycolic acid ester and trimethylene carbonate linkages; slow release drug delivery systems - Google Patents

Di- and triblock copolymers comprising polyalkylene oxide block and a block comprising glycolic acid ester and trimethylene carbonate linkages; slow release drug delivery systems

Info

Publication number
NZ221647A
NZ221647A NZ221647A NZ22164787A NZ221647A NZ 221647 A NZ221647 A NZ 221647A NZ 221647 A NZ221647 A NZ 221647A NZ 22164787 A NZ22164787 A NZ 22164787A NZ 221647 A NZ221647 A NZ 221647A
Authority
NZ
New Zealand
Prior art keywords
block
acid ester
drug delivery
delivery systems
glycolic acid
Prior art date
Application number
NZ221647A
Other languages
English (en)
Inventor
Donald James Casey
Louis Rosati
Peter Kendrick Jarrett
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/903,797 external-priority patent/US4716203A/en
Priority claimed from US06/903,801 external-priority patent/US4882168A/en
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of NZ221647A publication Critical patent/NZ221647A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/64Polyesters containing both carboxylic ester groups and carbonate groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2031Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Materials For Medical Uses (AREA)
NZ221647A 1986-09-05 1987-09-02 Di- and triblock copolymers comprising polyalkylene oxide block and a block comprising glycolic acid ester and trimethylene carbonate linkages; slow release drug delivery systems NZ221647A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/903,797 US4716203A (en) 1986-09-05 1986-09-05 Diblock and triblock copolymers
US06/903,801 US4882168A (en) 1986-09-05 1986-09-05 Polyesters containing alkylene oxide blocks as drug delivery systems

Publications (1)

Publication Number Publication Date
NZ221647A true NZ221647A (en) 1990-09-26

Family

ID=27129378

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ221647A NZ221647A (en) 1986-09-05 1987-09-02 Di- and triblock copolymers comprising polyalkylene oxide block and a block comprising glycolic acid ester and trimethylene carbonate linkages; slow release drug delivery systems

Country Status (13)

Country Link
EP (1) EP0258780B1 (enExample)
KR (1) KR880003985A (enExample)
AU (1) AU605172B2 (enExample)
BR (1) BR8704648A (enExample)
CA (1) CA1283988C (enExample)
DE (1) DE3786309T2 (enExample)
DK (1) DK462287A (enExample)
ES (1) ES2058081T3 (enExample)
FI (1) FI873840A7 (enExample)
GR (1) GR3008526T3 (enExample)
HU (1) HU205711B (enExample)
IL (1) IL83764A (enExample)
NZ (1) NZ221647A (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9401703A (nl) * 1994-10-14 1996-05-01 Rijksuniversiteit Kauwgom.
US5702717A (en) * 1995-10-25 1997-12-30 Macromed, Inc. Thermosensitive biodegradable polymers based on poly(ether-ester)block copolymers
US5665428A (en) * 1995-10-25 1997-09-09 Macromed, Inc. Preparation of peptide containing biodegradable microspheres by melt process
DE19726412A1 (de) * 1997-06-21 1998-12-24 Merck Patent Gmbh Implantatmaterial mit einer Träger-Wirkstoff-Kombination
US6201072B1 (en) 1997-10-03 2001-03-13 Macromed, Inc. Biodegradable low molecular weight triblock poly(lactide-co- glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
US6117949A (en) * 1998-10-01 2000-09-12 Macromed, Inc. Biodegradable low molecular weight triblock poly (lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
KR20010030891A (ko) * 1997-10-03 2001-04-16 마크로메드 인코퍼레이션 가역적 열 겔화 성질을 갖는 생분해성 저분자량 트리블럭폴리(락티드-코-글리콜리드) 폴리에틸렌 글리콜 공중합체
US6004573A (en) * 1997-10-03 1999-12-21 Macromed, Inc. Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
US7662409B2 (en) 1998-09-25 2010-02-16 Gel-Del Technologies, Inc. Protein matrix materials, devices and methods of making and using thereof
US7018645B1 (en) 2000-04-27 2006-03-28 Macromed, Inc. Mixtures of various triblock polyester polyethylene glycol copolymers having improved gel properties
AU2002249101B2 (en) 2001-03-23 2005-10-20 Gumlink A/S Coated degradable chewing gum with improved shelf life and process for preparing same
WO2002076228A1 (en) * 2001-03-23 2002-10-03 Gumlink A/S Degradable resin substitute for chewing gum
EP1408876A4 (en) 2001-06-22 2004-09-22 Durect Corp ZERO ORDER COAXIAL IMPLANTS WITH EXTENDED RELEASE
EP1476489B8 (en) 2002-02-15 2008-10-08 Nektar Therapeutics Al, Corporation Hydrolytically degradable alkylene oxide based polymers
CA2483778A1 (en) 2002-04-29 2003-11-13 Gel-Del Technologies, Inc. Biomatrix structural containment and fixation systems and methods of use thereof
EP1504047B1 (en) * 2002-05-03 2007-12-12 Janssen Pharmaceutica N.V. Polymeric microemulsions
US7649023B2 (en) 2002-06-11 2010-01-19 Novartis Ag Biodegradable block copolymeric compositions for drug delivery
BRPI0314042B8 (pt) 2002-09-06 2021-05-25 Calando Pharmaceuticals Inc polímeros à base de ciclodextrina para o fornecimento de agentes terapêuticos ligados a eles por covalência
WO2004028268A1 (en) 2002-09-24 2004-04-08 Gumlink A/S Chewing gum comprising at least two different biodegradable polymers
ATE404072T1 (de) 2002-09-24 2008-08-15 Gumlink As Biologisch abbaubarer kaugummi enthaltend wenigstens ein biologish abbaubares polymer mit hochmolekularem gewicht
DE60323055D1 (de) 2003-05-06 2008-10-02 Gumlinck As Methode zur Herstellung von Kaugummigranulat und komprimierten Kaugummiprodukten, sowie ein Kaugummigranuliersystem
EP1474995B1 (en) 2003-05-06 2012-11-14 Gumlink A/S A method for producing chewing gum granules, a gum composition extruder and granulating system, and a chewing gum product
US8465537B2 (en) 2003-06-17 2013-06-18 Gel-Del Technologies, Inc. Encapsulated or coated stent systems
EP1660013A4 (en) 2003-08-26 2011-07-20 Gel Del Technologies Inc BIOMATERIAL AND PROTEIN BIOCOACERVATES, METHODS OF MAKING AND USING THEM
US8529939B2 (en) 2003-12-08 2013-09-10 Gel-Del Technologies, Inc. Mucoadhesive drug delivery devices and methods of making and using thereof
US20080176958A1 (en) 2007-01-24 2008-07-24 Insert Therapeutics, Inc. Cyclodextrin-based polymers for therapeutics delivery
WO2009086483A2 (en) 2007-12-26 2009-07-09 Gel-Del Technologies, Inc. Biocompatible protein particles, particle devices and methods thereof
WO2010057177A2 (en) 2008-11-17 2010-05-20 Gel-Del Technologies, Inc. Protein biomaterial and biocoacervate vessel graft systems and methods of making and using thereof
US20110160159A1 (en) 2009-09-15 2011-06-30 John Ryan Treatment of cancer
WO2011146638A1 (en) 2010-05-18 2011-11-24 Cerulean Pharma Inc. Compositions and methods for treatment of autoimmune and other diseases
US20140094432A1 (en) 2012-10-02 2014-04-03 Cerulean Pharma Inc. Methods and systems for polymer precipitation and generation of particles
EP4192509A1 (en) 2020-08-05 2023-06-14 Ellipses Pharma Ltd Treatment of cancer using a cyclodextrin-containing polymer-topoisomerase inhibitor conjugate and a parp inhibitor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3736646A (en) * 1971-10-18 1973-06-05 American Cyanamid Co Method of attaching surgical needles to multifilament polyglycolic acid absorbable sutures
US4047533A (en) * 1976-09-20 1977-09-13 American Cyanamid Company Absorbable surgical sutures coated with polyoxyethylene-polyoxypropylene copolymer lubricant
US4429080A (en) * 1982-07-01 1984-01-31 American Cyanamid Company Synthetic copolymer surgical articles and method of manufacturing the same
US4438253A (en) * 1982-11-12 1984-03-20 American Cyanamid Company Poly(glycolic acid)/poly(alkylene glycol) block copolymers and method of manufacturing the same
US4452973A (en) * 1982-11-12 1984-06-05 American Cyanamid Company Poly(glycolic acid)/poly(oxyethylene) triblock copolymers and method of manufacturing the same

Also Published As

Publication number Publication date
EP0258780A3 (en) 1988-05-18
IL83764A (en) 1991-05-12
FI873840L (fi) 1988-03-06
AU605172B2 (en) 1991-01-10
HU205711B (en) 1992-06-29
DK462287A (da) 1988-03-06
EP0258780A2 (en) 1988-03-09
KR880003985A (ko) 1988-05-31
DK462287D0 (da) 1987-09-04
EP0258780B1 (en) 1993-06-23
FI873840A7 (fi) 1988-03-06
CA1283988C (en) 1991-05-07
IL83764A0 (en) 1988-02-29
DE3786309T2 (de) 1994-02-10
ES2058081T3 (es) 1994-11-01
BR8704648A (pt) 1988-04-26
DE3786309D1 (de) 1993-07-29
FI873840A0 (fi) 1987-09-04
GR3008526T3 (enExample) 1993-10-29
HUT52945A (en) 1990-09-28
AU7797087A (en) 1988-03-10

Similar Documents

Publication Publication Date Title
NZ221647A (en) Di- and triblock copolymers comprising polyalkylene oxide block and a block comprising glycolic acid ester and trimethylene carbonate linkages; slow release drug delivery systems
NZ231579A (en) Aerosol formulation containing a medicament and tetrafluoroethane
DE3372103D1 (en) Poly(glycolic acid)/poly(oxyethylene)triblock copolymers and method of manufacturing the same
NZ225394A (en) A tablet having improved bioadhesion to mucous membranes comprising a biopolymer and a polyol
AU8235591A (en) Poly(alkylene oxide) amino acid copolymers and drug carriers and charged copolymers based thereon
AU638768B2 (en) Pharmaceutical and cosmetic depigmentation compositions with a caffeic acid base
NZ216662A (en) Capsule made from polyalkylene glycol and poly(ethylene oxide)
IL84945A (en) Renin inhibiting peptidyl aminodiols and pharmaceutical compositions comprising them
NZ221306A (en) 2-component immunoadjuvant comprising a mycobacterial free immunoadjuvant oil and a polycationic polyelectrolyte immunoadjuvant and vaccines thereof
AU3511889A (en) Pyridonecarboxylic acids and antibacterial agents
IL84105A0 (en) 1-tertiary-alkyl-substituted naphthyridine-and quinoline-carboxylic acids and salts thereof and pharmaceutical compositions containing them
IL93954A0 (en) 5-alkylquinolonecarboxylic acids,their preparation and medicaments containing them
IL87800A0 (en) Dioxolane-2-carboxylic acids and pharmaceutical compositions comprising them
GB2224932B (en) Pharmaceutical solutions comprising cromoglycic acid and salbutamol
EP0410422A3 (en) A highly absorbable pharmaceutical composition
AU4675989A (en) Rare earth oxides and a process for their preparation
NZ227669A (en) Amino acid glycerides and pharmaceutical compositions thereof
NZ226446A (en) Pharmaceutical composition comprising a piperidinoalkanol derivative, nonionic surfactants and calcium carbonate
AU6442290A (en) Recorded message delivery system
ZA893123B (en) Novel processes and products involving yttrium-alkaline earth-bismuth-copper oxides
IL82726A (en) Pharmaceutical compositions comprising anticonvulsively active 1-phenalkylimidazole-4-and/or-5-carboxamides and certain novel phenalkylimidazoles and their manufacture
IL92854A0 (en) Controlled release,low-dose aspirin formulation and its preparation
AU5125390A (en) Substituted (quinolin-2-yl-methoxy)phenyl-n,n'- sulphonylureas, processes for their preparation and their use in medicaments
GB2204790B (en) Pharmaceutical compositions comprising a quinoline dicarboxylic acid and an anticholinergic agent
IL96409A0 (en) Biodegradable,water-soluble polycarboxylic acid copolymers,compositions containing them,and their use